BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okuro M, Fujiki N, Kotorii N, Ishimaru Y, Sokoloff P, Nishino S. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. Sleep 2010;33:930-42. [PMID: 20614853 DOI: 10.1093/sleep/33.7.930] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Mitra S, Bult-Ito A. Bidirectional Behavioral Selection in Mice: A Novel Pre-clinical Approach to Examining Compulsivity. Front Psychiatry 2021;12:716619. [PMID: 34566718 DOI: 10.3389/fpsyt.2021.716619] [Reference Citation Analysis]
2 Wei Y, Xu J, Miao S, Wei K, Peng L, Wang Y, Wei X. Recent advances in the utilization of tea active ingredients to regulate sleep through neuroendocrine pathway, immune system and intestinal microbiota. Crit Rev Food Sci Nutr 2022;:1-29. [PMID: 35266837 DOI: 10.1080/10408398.2022.2048291] [Reference Citation Analysis]
3 Lee HJ, Lee SY, Jang D, Chung SY, Shim I. Sedative Effect of Sophora flavescens and Matrine. Biomol Ther (Seoul) 2017;25:390-5. [PMID: 28190318 DOI: 10.4062/biomolther.2016.156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
4 Jacobson KA, Müller CE. Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology. 2016;104:31-49. [PMID: 26686393 DOI: 10.1016/j.neuropharm.2015.12.001] [Cited by in Crossref: 139] [Cited by in F6Publishing: 127] [Article Influence: 19.9] [Reference Citation Analysis]
5 Huang YW, Xu HH, Wang SM, Zhao Y, Huang YM, Li RB, Wang XJ, Hao SM, Sheng J. Absorption of caffeine in fermented Pu-er tea is inhibited in mice. Food Funct 2014;5:1520-8. [PMID: 24836454 DOI: 10.1039/c4fo00051j] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Choi EJ, Bae SH, Park JB, Kwon MJ, Jang SM, Zheng YF, Lee YS, Lee S, Bae SK. Simultaneous quantification of caffeine and its three primary metabolites in rat plasma by liquid chromatography–tandem mass spectrometry. Food Chemistry 2013;141:2735-42. [DOI: 10.1016/j.foodchem.2013.05.069] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
7 Martínez-lópez S, Sarriá B, Gómez-juaristi M, Goya L, Mateos R, Bravo-clemente L. Theobromine, caffeine, and theophylline metabolites in human plasma and urine after consumption of soluble cocoa products with different methylxanthine contents. Food Research International 2014;63:446-55. [DOI: 10.1016/j.foodres.2014.03.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
8 Raineri M, González B, Rivero-Echeto C, Muñiz JA, Gutiérrez ML, Ghanem CI, Cadet JL, García-Rill E, Urbano FJ, Bisagno V. Differential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in mice. Neurotox Res 2015;27:71-83. [PMID: 25261212 DOI: 10.1007/s12640-014-9493-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
9 Mahoney CE, Mochizuki T, Scammell TE. Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice. Sleep 2020;43:zsz302. [PMID: 31830270 DOI: 10.1093/sleep/zsz302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
10 Xing D, Yoo C, Gonzalez D, Jenkins V, Nottingham K, Dickerson B, Leonard M, Ko J, Faries M, Kephart W, Purpura M, Jäger R, Wells SD, Sowinski R, Rasmussen CJ, Kreider RB. Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial. Nutrients 2021;13:4478. [PMID: 34960030 DOI: 10.3390/nu13124478] [Reference Citation Analysis]
11 Sato M, Sagawa Y, Hirai N, Sato S, Okuro M, Kumar S, Kanbayashi T, Shimizu T, Sakai N, Nishino S. Noninvasive detection of sleep/wake changes and cataplexy-like behaviors in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset. Exp Neurol 2014;261:744-51. [PMID: 25118620 DOI: 10.1016/j.expneurol.2014.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Vivanco P, Studholme KM, Morin LP. Drugs that prevent mouse sleep also block light-induced locomotor suppression, circadian rhythm phase shifts and the drop in core temperature. Neuroscience 2013;254:98-109. [PMID: 24056197 DOI: 10.1016/j.neuroscience.2013.09.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
13 Oishi Y, Williams RH, Agostinelli L, Arrigoni E, Fuller PM, Mochizuki T, Saper CB, Scammell TE. Role of the medial prefrontal cortex in cataplexy. J Neurosci 2013;33:9743-51. [PMID: 23739971 DOI: 10.1523/JNEUROSCI.0499-13.2013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
14 Sakai N, Chikahisa S, Nishino S. Stimulants in Excessive Daytime Sleepiness. Sleep Medicine Clinics 2010;5:591-607. [DOI: 10.1016/j.jsmc.2010.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Schepici G, Silvestro S, Bramanti P, Mazzon E. Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson's Disease. Int J Mol Sci 2020;21:E4766. [PMID: 32635541 DOI: 10.3390/ijms21134766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Schmitt GC, Arbo MD, Lorensi AL, Maciel ES, Krahn CL, Mariotti KC, Dallegrave E, Leal MB, Limberger RP. Toxicological effects of a mixture used in weight loss products: p-synephrine associated with ephedrine, salicin, and caffeine. Int J Toxicol 2012;31:184-91. [PMID: 22408069 DOI: 10.1177/1091581811435708] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
17 Burgess CR, Oishi Y, Mochizuki T, Peever JH, Scammell TE. Amygdala lesions reduce cataplexy in orexin knock-out mice. J Neurosci 2013;33:9734-42. [PMID: 23739970 DOI: 10.1523/JNEUROSCI.5632-12.2013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
18 Chikahisa S, Kodama T, Soya A, Sagawa Y, Ishimaru Y, Séi H, Nishino S. Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states. PLoS One 2013;8:e78434. [PMID: 24205232 DOI: 10.1371/journal.pone.0078434] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
19 Takahashi T, Noriaki S, Matsumura M, Li C, Takahashi K, Nishino S. Advances in pharmaceutical treatment options for narcolepsy. Expert Opinion on Orphan Drugs 2018;6:597-610. [DOI: 10.1080/21678707.2018.1521267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Sagawa Y, Sato M, Sakai N, Chikahisa S, Chiba S, Maruyama T, Yamamoto J, Nishino S. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice. Neuropharmacology 2016;110:268-76. [PMID: 27474349 DOI: 10.1016/j.neuropharm.2016.07.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
21 Lin Y, Weibel J, Landolt H, Santini F, Garbazza C, Kistler J, Rehm S, Rentsch K, Borgwardt S, Cajochen C, Reichert CF. Time to Recover From Daily Caffeine Intake. Front Nutr 2022;8:787225. [DOI: 10.3389/fnut.2021.787225] [Reference Citation Analysis]
22 Yoo C, Xing D, Gonzalez D, Jenkins V, Nottingham K, Dickerson B, Leonard M, Ko J, Faries M, Kephart W, Purpura M, Jäger R, Wells SD, Sowinski R, Rasmussen CJ, Kreider RB. Acute Paraxanthine Ingestion Improves Cognition and Short-Term Memory and Helps Sustain Attention in a Double-Blind, Placebo-Controlled, Crossover Trial. Nutrients 2021;13:3980. [PMID: 34836235 DOI: 10.3390/nu13113980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ferré S, Orrú M, Guitart X. Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission. J Caffeine Res 2013;3:72-8. [PMID: 24761277 DOI: 10.1089/jcr.2013.0006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Rogers PJ, Heatherley SV, Mullings EL, Smith JE. Faster but not smarter: effects of caffeine and caffeine withdrawal on alertness and performance. Psychopharmacology (Berl) 2013;226:229-40. [PMID: 23108937 DOI: 10.1007/s00213-012-2889-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
25 de Biase S, Nilo A, Gigli GL, Valente M. Investigational therapies for the treatment of narcolepsy. Expert Opin Investig Drugs 2017;26:953-63. [PMID: 28726523 DOI: 10.1080/13543784.2017.1356819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Ruiz-Medina J, Pinto-Xavier A, Rodríguez-Arias M, Miñarro J, Valverde O. Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice. Psychopharmacology (Berl) 2013;226:433-44. [PMID: 23187789 DOI: 10.1007/s00213-012-2918-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
27 Williams RH, Tsunematsu T, Thomas AM, Bogyo K, Yamanaka A, Kilduff TS. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy. J Neurosci 2019;39:9435-52. [PMID: 31628177 DOI: 10.1523/JNEUROSCI.0311-19.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
28 Hertzsch R, Richter A. Systematic analysis to assess the scientific validity of the international residue limits for caffeine and theophylline in horse-racing. Vet Rec 2019;185:230. [PMID: 31409753 DOI: 10.1136/vr.105404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
29 Kantor S, Mochizuki T, Lops SN, Ko B, Clain E, Clark E, Yamamoto M, Scammell TE. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice. Sleep 2013;36:1129-38. [PMID: 23904672 DOI: 10.5665/sleep.2870] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
30 Spindler SR, Mote PL, Flegal JM, Teter B. Influence on longevity of blueberry, cinnamon, green and black tea, pomegranate, sesame, curcumin, morin, pycnogenol, quercetin, and taxifolin fed iso-calorically to long-lived, F1 hybrid mice. Rejuvenation Res 2013;16:143-51. [PMID: 23432089 DOI: 10.1089/rej.2012.1386] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
31 Mitra S, Santana Miranda V, McMillan C, Dykes D, Mucha M, Marth TE, Poe B, Basu DG, Bult-Ito A. Trait specific modulatory effects of caffeine exposure on compulsive-like behaviors in a spontaneous mouse model of obsessive-compulsive disorder. Behav Pharmacol 2020;31:622-32. [PMID: 32427622 DOI: 10.1097/FBP.0000000000000570] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Duan WJ, Liang L, Pan MH, Lu DH, Wang TM, Li SB, Zhong HB, Yang XJ, Cheng Y, Liu B, Li WX, Kurihara H, Bi W, Li YF, He RR. Theacrine, a purine alkaloid from kucha, protects against Parkinson's disease through SIRT3 activation. Phytomedicine 2020;77:153281. [PMID: 32707370 DOI: 10.1016/j.phymed.2020.153281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Orrú M, Guitart X, Karcz-Kubicha M, Solinas M, Justinova Z, Barodia SK, Zanoveli J, Cortes A, Lluis C, Casado V, Moeller FG, Ferré S. Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans. Neuropharmacology 2013;67:476-84. [PMID: 23261866 DOI: 10.1016/j.neuropharm.2012.11.029] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
34 Aldosari MS, Olaish AH, Nashwan SZ, Abulmeaty MMA, BaHammam AS. The effects of caffeine on drowsiness in patients with narcolepsy: a double-blind randomized controlled pilot study. Sleep Breath 2020;24:1675-84. [PMID: 32215834 DOI: 10.1007/s11325-020-02065-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Lazarus M, Huang Z, Lu J, Urade Y, Chen J. How do the basal ganglia regulate sleep–wake behavior? Trends in Neurosciences 2012;35:723-32. [DOI: 10.1016/j.tins.2012.07.001] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 8.3] [Reference Citation Analysis]
36 Reichert CF, Deboer T, Landolt HP. Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives. J Sleep Res 2022. [PMID: 35575450 DOI: 10.1111/jsr.13597] [Reference Citation Analysis]